Tabarraee M, Rezaee A, Abolghasemi S, Ghadiany M, Tavakoli Ardakani M, Mahdizadeh M, Hamidi N, Ghasemi K. Assessment of Effectiveness and Adverse Effect of New Combination Chemotherapy (irinotecan, cisplatin, and dexamethasone) in Relapse and Refractory Hodgkin Lymphoma. Int J Hematol Oncol Stem Cell Res. 2023;17(3):194-199.